00850nas a2200241 4500000000100000008004100001260001300042653001500055653002300070653001200093653001100105653001200116653001100128653002500139100001200164700001600176700001200192245011500204300001100319490000700330520025700337022001400594 1983 d c1983 Dec10aAntibodies10aAntibody Formation10aDapsone10aHumans10aleprosy10aLipids10aMycobacterium leprae1 aMalik U1 aKhuller G K1 aKumar B00aSuppression of the antibody response to sulfolipids in leprosy patients by 4,4'-diaminodiphenyl sulfone (DDS). a579-830 v493 a

Antibodies to sulfolipids were demonstrated in patients suffering from lepromatous leprosy. The antibody titre was found to decrease gradually on treatment with DDS. This effect was maximum for patients undergoing treatment for more than 1 year.

 a0003-6072